Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Membrane Chromatography Market by Technique (Ion Exchange Membrane Chromatography, Anion Exchange Membrane Chromatography, Cation Exchange Membrane Chromatography, Affinity Membrane Chromatography, Hydrophobic Interaction Membrane Chromatography), by Opreation Mode (Flow-through Membrane Chromatography, Bind-elute Membrane Chromatography) and by End User (CROs, Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

A11218

Pages: NA

Charts: NA

Tables: NA

Chromatography membranes use the combination of ion exchange chemistry with the high flow and processing simplicity of pre-packaged capsules. The upper surface area and large pore sizes provide high dynamic binding capacities, especially for large molecules and particles, and are easily incorporated into a process for the removal of impurities or for the purification of select molecules (coagulation factors) or viral vectors (AAV, Lentivirus). The range of scalable formats available allows them to be used in a variety of purification processes, from laboratory to manufacturing scale. The advantages offered by the membrane chromatography include, high binding efficiency due to direct access to the binding groups, even at high flow rates, lower cost of operation and vast scalability and flexibility.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies came together governments around the globe are working to address the COVID-19 outbreak, from supporting the R&D of vaccines to planning for medicines supply chain challenges. The research to the development of about 115 vaccine candidates and 155 molecules are in the R&D pipeline. The commonly used drug Hydroxychloroquine is seen to be experiencing high demand. This high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are having lesser resources of these drugs. The increase in demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a lucrative growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the industry includes, rising biopharmaceutical R&D which would help the membrane chromatography market grow in the forecast period. The surge in regulatory scrutiny on the cleaning validation techniques of the downstream purification processes is also anticipated to help the market boost in the coming years. The benefits offered by the advanced membrane chromatography methods is expected to fulfill the demand posed by the membrane chromatography market would propel the industry grow. Moreover, the lack of skilled professionals for the job is expected to impede the industry growth in the near future.

New product advancements to flourish the market

In June 2017, Sartorius Stedim Biotech (SSB) expanded its range of single-use membrane chromatography solutions with Sartobind Cassettes. This convenient, pod-like modular system has been developed for commercial applications in both capture and polishing.

In January 2015, 3M Purification’s new purification technology platform, under the 3M Emphaze brand, was launched, which is designed to help biopharmaceutical manufacturers achieve high product purity early in the manufacturing process, improving efficiency and process economics. The new 3M Emphaze AEX Hybrid Purifier, the first in a series of single-use chromatographic products, uniquely combines three 3M core technologies, advanced polymer materials, fine fiber nonwovens, and porous membranes, into a novel purification media.

Surge in mergers and acquisitions to boost the market

In March 2020, Danaher Corporation announced the completion of its acquisition of the Biopharma business from General Electric Company's Life Sciences division. Furthermore, as part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment.

In October 2019, Sartorius, which is a leading partner to the biopharmaceutical industry and laboratories, had signed an agreement to acquire parts of Danaher’s Life Science portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-digit profit margins. They employ around 300 people worldwide. The proposed transaction is expected to be completed in the first quarter of 2020 and is subject to customary closing conditions and the successful acquisition of the GE Biopharma business by Danaher.

Key benefits of the report:

  • This study presents the analytical depiction of the global membrane chromatography industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global membrane chromatography market share.
  • The current market is quantitatively analyzed to highlight the global membrane chromatography market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the membrane chromatography market.
  • The report provides a detailed global membrane chromatography market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the membrane chromatography market research report:

  • Who are the leading market players active in the membrane chromatography market?
  • What current trends will influence the membrane chromatography market in the next few years?
  • What are the driving factors, restraints, and opportunities in the membrane chromatography market?
  • What are the projections for the future that would help in tasking further strategic steps?

Key Market Segments

  • By Technique
    • Ion Exchange Membrane Chromatography
    • Anion Exchange Membrane Chromatography
    • Cation Exchange Membrane Chromatography
    • Affinity Membrane Chromatography
    • Hydrophobic Interaction Membrane Chromatography
  • By Opreation Mode
    • Flow-through Membrane Chromatography
    • Bind-elute Membrane Chromatography
  • By End User
    • CROs
    • Pharmaceutical and Biopharmaceutical Companies
    • Academic and Research Institutes
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • Uk
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Sartorius AG
  • Asahi Kasei Corporation
  • Danaher Corporation
  • 3M Company
  • Membrane Solutions LLC
  • Cole-Parmer Instrument Company
  • Thermo Fisher Scientific Inc.
  • Merck Millipore
  • GVS Group
  • Purilogics


Other Players

  • Restek Corporation
  • Regis Technologies Inc
  • GL Sciences Inc
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Technique

    • 4.2. Ion Exchange Membrane Chromatography

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Anion Exchange Membrane Chromatography

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Cation Exchange Membrane Chromatography

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Affinity Membrane Chromatography

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Hydrophobic Interaction Membrane Chromatography

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: MEMBRANE CHROMATOGRAPHY MARKET, BY OPREATION MODE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Opreation Mode

    • 5.2. Flow-through Membrane Chromatography

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Bind-elute Membrane Chromatography

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: MEMBRANE CHROMATOGRAPHY MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. CROs

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Pharmaceutical And Biopharmaceutical Companies

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Academic And Research Institutes

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: MEMBRANE CHROMATOGRAPHY MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Technique

      • 7.2.3. Market Size and Forecast, By Opreation Mode

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Membrane Chromatography Market

        • 7.2.6.1. Market Size and Forecast, By Technique
        • 7.2.6.2. Market Size and Forecast, By Opreation Mode
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Membrane Chromatography Market

        • 7.2.7.1. Market Size and Forecast, By Technique
        • 7.2.7.2. Market Size and Forecast, By Opreation Mode
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Membrane Chromatography Market

        • 7.2.8.1. Market Size and Forecast, By Technique
        • 7.2.8.2. Market Size and Forecast, By Opreation Mode
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Technique

      • 7.3.3. Market Size and Forecast, By Opreation Mode

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Membrane Chromatography Market

        • 7.3.6.1. Market Size and Forecast, By Technique
        • 7.3.6.2. Market Size and Forecast, By Opreation Mode
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Membrane Chromatography Market

        • 7.3.7.1. Market Size and Forecast, By Technique
        • 7.3.7.2. Market Size and Forecast, By Opreation Mode
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Membrane Chromatography Market

        • 7.3.8.1. Market Size and Forecast, By Technique
        • 7.3.8.2. Market Size and Forecast, By Opreation Mode
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Membrane Chromatography Market

        • 7.3.9.1. Market Size and Forecast, By Technique
        • 7.3.9.2. Market Size and Forecast, By Opreation Mode
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Membrane Chromatography Market

        • 7.3.10.1. Market Size and Forecast, By Technique
        • 7.3.10.2. Market Size and Forecast, By Opreation Mode
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Membrane Chromatography Market

        • 7.3.11.1. Market Size and Forecast, By Technique
        • 7.3.11.2. Market Size and Forecast, By Opreation Mode
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Membrane Chromatography Market

        • 7.3.12.1. Market Size and Forecast, By Technique
        • 7.3.12.2. Market Size and Forecast, By Opreation Mode
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Technique

      • 7.4.3. Market Size and Forecast, By Opreation Mode

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Membrane Chromatography Market

        • 7.4.6.1. Market Size and Forecast, By Technique
        • 7.4.6.2. Market Size and Forecast, By Opreation Mode
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Membrane Chromatography Market

        • 7.4.7.1. Market Size and Forecast, By Technique
        • 7.4.7.2. Market Size and Forecast, By Opreation Mode
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Membrane Chromatography Market

        • 7.4.8.1. Market Size and Forecast, By Technique
        • 7.4.8.2. Market Size and Forecast, By Opreation Mode
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Membrane Chromatography Market

        • 7.4.9.1. Market Size and Forecast, By Technique
        • 7.4.9.2. Market Size and Forecast, By Opreation Mode
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Membrane Chromatography Market

        • 7.4.10.1. Market Size and Forecast, By Technique
        • 7.4.10.2. Market Size and Forecast, By Opreation Mode
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Membrane Chromatography Market

        • 7.4.11.1. Market Size and Forecast, By Technique
        • 7.4.11.2. Market Size and Forecast, By Opreation Mode
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Membrane Chromatography Market

        • 7.4.12.1. Market Size and Forecast, By Technique
        • 7.4.12.2. Market Size and Forecast, By Opreation Mode
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Membrane Chromatography Market

        • 7.4.13.1. Market Size and Forecast, By Technique
        • 7.4.13.2. Market Size and Forecast, By Opreation Mode
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Membrane Chromatography Market

        • 7.4.14.1. Market Size and Forecast, By Technique
        • 7.4.14.2. Market Size and Forecast, By Opreation Mode
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Technique

      • 7.5.3. Market Size and Forecast, By Opreation Mode

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Membrane Chromatography Market

        • 7.5.6.1. Market Size and Forecast, By Technique
        • 7.5.6.2. Market Size and Forecast, By Opreation Mode
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Membrane Chromatography Market

        • 7.5.7.1. Market Size and Forecast, By Technique
        • 7.5.7.2. Market Size and Forecast, By Opreation Mode
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Membrane Chromatography Market

        • 7.5.8.1. Market Size and Forecast, By Technique
        • 7.5.8.2. Market Size and Forecast, By Opreation Mode
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Membrane Chromatography Market

        • 7.5.9.1. Market Size and Forecast, By Technique
        • 7.5.9.2. Market Size and Forecast, By Opreation Mode
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Membrane Chromatography Market

        • 7.5.10.1. Market Size and Forecast, By Technique
        • 7.5.10.2. Market Size and Forecast, By Opreation Mode
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Membrane Chromatography Market

        • 7.5.11.1. Market Size and Forecast, By Technique
        • 7.5.11.2. Market Size and Forecast, By Opreation Mode
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Danaher Corporation

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Sartorius AG

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Merck Millipore

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Purilogics

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Thermo Fisher Scientific Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. 3M Company

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Asahi Kasei Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Membrane Solutions LLC

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Cole-Parmer Instrument Company

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. GVS Group

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR ION EXCHANGE MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR ANION EXCHANGE MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR CATION EXCHANGE MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR AFFINITY MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR FLOW-THROUGH MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR BIND-ELUTE MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR CROS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. U.S. MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 21. U.S. MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. CANADA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 23. CANADA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 24. CANADA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. ITALY MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 39. ITALY MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 40. ITALY MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. UK MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 45. UK MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 46. UK MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. CHINA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 58. CHINA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 59. CHINA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. INDIA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 64. INDIA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 65. INDIA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA MEMBRANE CHROMATOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 97. UAE MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 98. UAE MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 99. UAE MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA MEMBRANE CHROMATOGRAPHY, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA MEMBRANE CHROMATOGRAPHY, BY OPREATION MODE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA MEMBRANE CHROMATOGRAPHY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 106. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 107. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 108. DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 109. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 110. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. SARTORIUS AG: KEY EXECUTIVES
  • TABLE 112. SARTORIUS AG: COMPANY SNAPSHOT
  • TABLE 113. SARTORIUS AG: OPERATING SEGMENTS
  • TABLE 114. SARTORIUS AG: PRODUCT PORTFOLIO
  • TABLE 115. SARTORIUS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. MERCK MILLIPORE: KEY EXECUTIVES
  • TABLE 117. MERCK MILLIPORE: COMPANY SNAPSHOT
  • TABLE 118. MERCK MILLIPORE: OPERATING SEGMENTS
  • TABLE 119. MERCK MILLIPORE: PRODUCT PORTFOLIO
  • TABLE 120. MERCK MILLIPORE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. PURILOGICS: KEY EXECUTIVES
  • TABLE 122. PURILOGICS: COMPANY SNAPSHOT
  • TABLE 123. PURILOGICS: OPERATING SEGMENTS
  • TABLE 124. PURILOGICS: PRODUCT PORTFOLIO
  • TABLE 125. PURILOGICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 127. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 128. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 129. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 130. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 131. 3M COMPANY: KEY EXECUTIVES
  • TABLE 132. 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 133. 3M COMPANY: OPERATING SEGMENTS
  • TABLE 134. 3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 135. 3M COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 136. ASAHI KASEI CORPORATION: KEY EXECUTIVES
  • TABLE 137. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
  • TABLE 138. ASAHI KASEI CORPORATION: OPERATING SEGMENTS
  • TABLE 139. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO
  • TABLE 140. ASAHI KASEI CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 141. MEMBRANE SOLUTIONS LLC: KEY EXECUTIVES
  • TABLE 142. MEMBRANE SOLUTIONS LLC: COMPANY SNAPSHOT
  • TABLE 143. MEMBRANE SOLUTIONS LLC: OPERATING SEGMENTS
  • TABLE 144. MEMBRANE SOLUTIONS LLC: PRODUCT PORTFOLIO
  • TABLE 145. MEMBRANE SOLUTIONS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. COLE-PARMER INSTRUMENT COMPANY: KEY EXECUTIVES
  • TABLE 147. COLE-PARMER INSTRUMENT COMPANY: COMPANY SNAPSHOT
  • TABLE 148. COLE-PARMER INSTRUMENT COMPANY: OPERATING SEGMENTS
  • TABLE 149. COLE-PARMER INSTRUMENT COMPANY: PRODUCT PORTFOLIO
  • TABLE 150. COLE-PARMER INSTRUMENT COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. GVS GROUP: KEY EXECUTIVES
  • TABLE 152. GVS GROUP: COMPANY SNAPSHOT
  • TABLE 153. GVS GROUP: OPERATING SEGMENTS
  • TABLE 154. GVS GROUP: PRODUCT PORTFOLIO
  • TABLE 155. GVS GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MEMBRANE CHROMATOGRAPHY MARKET
  • FIGURE 3. SEGMENTATION MEMBRANE CHROMATOGRAPHY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MEMBRANE CHROMATOGRAPHY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMEMBRANE CHROMATOGRAPHY MARKET
  • FIGURE 11. MEMBRANE CHROMATOGRAPHY MARKET SEGMENTATION, BY BY TECHNIQUE
  • FIGURE 12. MEMBRANE CHROMATOGRAPHY MARKET FOR ION EXCHANGE MEMBRANE CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MEMBRANE CHROMATOGRAPHY MARKET FOR ANION EXCHANGE MEMBRANE CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MEMBRANE CHROMATOGRAPHY MARKET FOR CATION EXCHANGE MEMBRANE CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MEMBRANE CHROMATOGRAPHY MARKET FOR AFFINITY MEMBRANE CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MEMBRANE CHROMATOGRAPHY MARKET FOR HYDROPHOBIC INTERACTION MEMBRANE CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MEMBRANE CHROMATOGRAPHY MARKET SEGMENTATION, BY BY OPREATION MODE
  • FIGURE 18. MEMBRANE CHROMATOGRAPHY MARKET FOR FLOW-THROUGH MEMBRANE CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MEMBRANE CHROMATOGRAPHY MARKET FOR BIND-ELUTE MEMBRANE CHROMATOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MEMBRANE CHROMATOGRAPHY MARKET SEGMENTATION, BY BY END USER
  • FIGURE 21. MEMBRANE CHROMATOGRAPHY MARKET FOR CROS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. MEMBRANE CHROMATOGRAPHY MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. MEMBRANE CHROMATOGRAPHY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 28. COMPETITIVE DASHBOARD
  • FIGURE 29. COMPETITIVE HEATMAP: MEMBRANE CHROMATOGRAPHY MARKET
  • FIGURE 30. TOP PLAYER POSITIONING, 2024
  • FIGURE 31. DANAHER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. SARTORIUS AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. SARTORIUS AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. SARTORIUS AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. MERCK MILLIPORE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. MERCK MILLIPORE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. MERCK MILLIPORE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. PURILOGICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. PURILOGICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. PURILOGICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. 3M COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. 3M COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. 3M COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. ASAHI KASEI CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. ASAHI KASEI CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. ASAHI KASEI CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. MEMBRANE SOLUTIONS LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. MEMBRANE SOLUTIONS LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. MEMBRANE SOLUTIONS LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. COLE-PARMER INSTRUMENT COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. COLE-PARMER INSTRUMENT COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. COLE-PARMER INSTRUMENT COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. GVS GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. GVS GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. GVS GROUP: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Membrane Chromatography Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue